Edition:
United Kingdom

InVivo Therapeutics Holdings Corp (NVIV.OQ)

NVIV.OQ on NASDAQ Stock Exchange Global Market

0.72USD
12 Jan 2018
Change (% chg)

$0.00 (+0.53%)
Prev Close
$0.71
Open
$0.72
Day's High
$0.73
Day's Low
$0.72
Volume
15,051
Avg. Vol
32,000
52-wk High
$4.95
52-wk Low
$0.62

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.00 -0.197
Mar '17 0.00 -0.199
FY 2016 Dec '16 0.00 -0.170
Sep '16 0.00 -0.194
Jun '16 0.00 -0.162
Mar '16 0.00 -0.235
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 0.00 0.00 0.00 0.00
Quarter Ending Jun-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-18 1 0.00 0.00 0.00 6.65
Earnings (per share)
Quarter Ending Mar-18 1 -0.17 -0.17 -0.17 -0.22
Quarter Ending Jun-18 1 -0.17 -0.17 -0.17 -0.22
Year Ending Dec-18 1 -0.61 -0.61 -0.61 -0.83
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 160.83 32.89
P/E High - Last 5 Yrs. 26.83 73.58 45.60
P/E Low - Last 5 Yrs. 26.83 20.07 24.32
Beta 3.34 0.91 0.89
Price to Sales (TTM) -- 3.21 5.41
Price to Book (MRQ) 2.80 3.98 5.38
Price to Tangible Book (MRQ) 2.80 4.98 6.76
Price to Cash Flow (TTM) -- 18.49 23.42
% Owned Institutions 18.71 19.72 1.81

Dividends

  Company industry sector
Dividend Yield -- 0.81 1.50
Dividend Yield - 5 Year Avg -- 0.76 1.51
Dividend 5 Year Growth Rate -- 7.72 5.22
Payout Ratio(TTM) -- 26.79 43.68

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 6.87 9.01
Sales (TTM) vs TTM 1 Yr. Ago -- 2.76 5.40
Sales - 5 Yr. Growth Rate -- 4.02 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago -21.24 50.27 19.39
EPS (TTM) vs TTM 1 Yr. Ago -15.83 -- --
EPS - 5 Yr. Growth Rate -- 4.22 10.80
Capital Spending - 5 Yr. Growth Rate -17.44 11.51 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.72 2.18
Current Ratio (MRQ) 5.89 2.21 2.97
LT Debt to Equity (MRQ) 3.32 39.98 11.90
Total Debt to Equity (MRQ) 5.62 49.02 16.16
Interest Coverage (TTM) -- 25.39 33.26

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.24 54.87
Gross Margin - 5 Yr. Avg. -- 54.00 52.46
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 16.29 15.31
Operating Margin (TTM) -- 7.59 7.77
Operating Margin - 5 Yr. Avg. -- 8.39 10.80
Pre-Tax Margin (TTM) -- 7.93 8.57
Pre-Tax Margin - 5 Yr. Avg. -- 7.54 11.21
Net Profit Margin (TTM) -- 5.86 4.88
Net Profit Margin - 5 Yr. Avg. -- 5.33 7.51
Effective Tax Rate (TTM) -- 17.89 23.08
Effective Tax Rate - 5 Yr. Avg. -- 20.48 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 15,602,270 859,857,503
Net Income/Employee (TTM) -658,405 1,310,816 101,151,730
Receivable Turnover (TTM) -- 5.23 5.76
Inventory Turnover (TTM) -- 4.57 3.33
Asset Turnover (TTM) 0.00 0.80 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -72.62 -1.93 10.99
Return on Assets - 5 Yr. Avg. -118.83 4.93 12.42
Return on Investment (TTM) -83.17 9.54 14.44
Return on Investment - 5 Yr. Avg. -273.41 6.74 16.26
Return on Equity (TTM) -86.11 14.96 16.10
Return on Equity - 5 Yr. Avg. -337.83 10.24 17.54
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 40.00 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for InVivo Therapeutics Holdings Corp

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 12.82%
# of Holders: 58
Total Shares Held: 4,388,321
3 Mo. Net Change: -330
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.